BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28777895)

  • 1. Cross-Cultural Adaptation and Psychometric Validation of the Serbian Version of the Central Sensitization Inventory.
    Knezevic A; Neblett R; Jeremic-Knezevic M; Tomasevic-Todorovic S; Boskovic K; Colovic P; Cuesta-Vargas A
    Pain Pract; 2018 Apr; 18(4):463-472. PubMed ID: 28777895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-cultural Adaptation and Psychometric Properties of the Greek Version of the Central Sensitization Inventory.
    Bilika P; Neblett R; Georgoudis G; Dimitriadis Z; Fandridis E; Strimpakos N; Kapreli E
    Pain Pract; 2020 Feb; 20(2):188-196. PubMed ID: 31605651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent and Discriminant Validity of the Serbian Version of the Central Sensitization Inventory.
    Knezevic A; Neblett R; Colovic P; Jeremic-Knezevic M; Bugarski-Ignjatovic V; Klasnja A; Pantelinac S; Pjevic M
    Pain Pract; 2020 Sep; 20(7):724-736. PubMed ID: 32285543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-Cultural Adaptation and Psychometric Properties of the European Portuguese Version of the Central Sensitization Inventory in Adolescents With Musculoskeletal Chronic Pain.
    Andias R; Silva AG
    Pain Pract; 2020 Jun; 20(5):480-490. PubMed ID: 32022985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-cultural adaptation and validation of the Finnish version of the central sensitization inventory and its relationship with dizziness and postural control.
    Mikkonen J; Luomajoki H; Airaksinen O; Neblett R; Selander T; Leinonen V
    BMC Neurol; 2021 Mar; 21(1):141. PubMed ID: 33784969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-cultural adaptation and psychometric validation of the Persian version of the central sensitization inventory.
    Noorollahzadeh K; Kahrizi S; Fesharaki MG; Heidarian M; Neblett R; Behzadipour S
    Musculoskelet Sci Pract; 2021 Feb; 51():102314. PubMed ID: 33360651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross cultural adaptation, validity, and reliability of Central Sensitization Inventory in Arabic language.
    Madi M; Hamzeh H; Abujaber S; Altubasi I
    Disabil Rehabil; 2022 Dec; 44(25):8075-8083. PubMed ID: 34813384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural adaptation and validation of the Chinese version of the short-form of the Central Sensitization Inventory (CSI-9) in patients with chronic pain: A single-center study.
    Liang D; Yu X; Guo X; Zhang J; Jiang R
    PLoS One; 2023; 18(3):e0282419. PubMed ID: 36928443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory.
    Chiarotto A; Viti C; Sulli A; Cutolo M; Testa M; Piscitelli D
    Musculoskelet Sci Pract; 2018 Oct; 37():20-28. PubMed ID: 29966856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Sensitisation Inventory-Thai version: translation, cross-cultural adaptation, and psychometric evaluation in chronic non-specific neck pain.
    Wiangkham T; Phungwattanakul N; Rinpol T; Somsiri A; Mainoiy S; Bannathong T; Sanso S; Kongmee I; Jaiyote S; Kuesoongnern S; Sookcharoen P; Laoruengthana A; Suwanmongkhon W; Luciano JV; Neblett R
    Disabil Rehabil; 2023 Dec; 45(25):4303-4310. PubMed ID: 36440688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-cultural adaptation and validation of the German Central Sensitization Inventory (CSI-GE).
    Klute M; Laekeman M; Kuss K; Petzke F; Dieterich A; Leha A; Neblett R; Ehrhardt S; Ulma J; Schäfer A
    BMC Musculoskelet Disord; 2021 Aug; 22(1):708. PubMed ID: 34407773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation, cross-cultural adaptation, and measurement properties of the Nepali version of the central sensitization inventory (CSI).
    Sharma S; Jha J; Pathak A; Neblett R
    BMC Neurol; 2020 Jul; 20(1):286. PubMed ID: 32718330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric validation of the Polish version of the Central Sensitization Inventory in subjects with chronic spinal pain.
    Kosińska B; Tarnacka B; Turczyn P; Gromadzka G; Malec-Milewska M; Janikowska-Hołowenko D; Neblett R
    BMC Neurol; 2021 Dec; 21(1):483. PubMed ID: 34893020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dutch Central Sensitization Inventory (CSI): Factor Analysis, Discriminative Power, and Test-Retest Reliability.
    Kregel J; Vuijk PJ; Descheemaeker F; Keizer D; van der Noord R; Nijs J; Cagnie B; Meeus M; van Wilgen P
    Clin J Pain; 2016 Jul; 32(7):624-30. PubMed ID: 26418360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological Distress and Widespread Pain Contribute to the Variance of the Central Sensitization Inventory: A Cross-Sectional Study in Patients with Chronic Pain.
    van Wilgen CP; Vuijk PJ; Kregel J; Voogt L; Meeus M; Descheemaeker F; Keizer D; Nijs J
    Pain Pract; 2018 Feb; 18(2):239-246. PubMed ID: 28449376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and psychometric validation of the central sensitization inventory.
    Mayer TG; Neblett R; Cohen H; Howard KJ; Choi YH; Williams MJ; Perez Y; Gatchel RJ
    Pain Pract; 2012 Apr; 12(4):276-85. PubMed ID: 21951710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Japanese version of the Central Sensitization Inventory in patients with musculoskeletal disorders.
    Tanaka K; Nishigami T; Mibu A; Manfuku M; Yono S; Shinohara Y; Tanabe A; Ono R
    PLoS One; 2017; 12(12):e0188719. PubMed ID: 29216211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural validity and reliability of the Spanish Central Sensitization Inventory in breast cancer survivors.
    Roldán-Jiménez C; Pajares B; Iglesias Campos M; Trinidad-Fernández M; Gutiérrez-Sánchez D; Ribelles N; Alba E; Cuesta-Vargas AI
    Pain Pract; 2021 Sep; 21(7):740-746. PubMed ID: 33768652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program.
    Neblett R; Hartzell MM; Williams M; Bevers KR; Mayer TG; Gatchel RJ
    Spine J; 2017 Dec; 17(12):1819-1829. PubMed ID: 28619687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric validation of the Serbian version of the Fear Avoidance Component Scale (FACS).
    Knezevic A; Neblett R; Gatchel RJ; Jeremic-Knezevic M; Bugarski-Ignjatovic V; Tomasevic-Todorovic S; Boskovic K; Cuesta-Vargas AI
    PLoS One; 2018; 13(9):e0204311. PubMed ID: 30248127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.